Advertisement

Acute Coronary Syndromes: Differences in Men and Women

  • Kris R. Kawamoto
  • Melinda B. Davis
  • Claire S. Duvernoy
Women and Ischemic Heart Disease (E. Jackson, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Women and Ischemic Heart Disease

Abstract

Purpose of Review

Increased awareness of cardiovascular disease in women has prompted studies to investigate gender-related disparities in acute coronary syndromes (ACSs). In this review, we discuss findings from current literature on the clinical presentation, pathophysiology, diagnosis, and management of ACS in women as compared to men.

Recent Findings

Emerging data show that cardiovascular disease (CVD) continues to be the leading cause of death in women and the annual mortality rate from CVD remains higher in women compared to men. Recent studies demonstrate sex-specific differences in patients presenting with ACS. Comorbidities, especially diabetes, are more common in young women compared with age-matched men who develop acute myocardial infarction (AMI). Women are more likely to have atypical symptoms and nonobstructive coronary disease on angiography. Women are less likely to receive guideline-based therapies. They have higher rates of peri-procedural complications with PCI and are less likely to be referred to cardiac rehabilitation.

Summary

Awareness of differences in the underlying pathophysiology of coronary disease in women compared to men may lead to improved gender-based diagnostic and treatment modalities. However, until more studies are performed, efforts should be directed toward improving delivery of current, gender-neutral guidelines in women just as in men.

Keywords

Acute coronary syndrome Women Nonobstructive coronary disease Gender differences Myocardial infarction 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Xu J, Murphy SL, Kochanek KD, Bastian BA. Deaths: final data for 2013. Natl Vital Stat Rep: Ctr Dis Control Prev, Natl Ctr Health Stat, Natl Vital Stat Syst. 2016;64(2):1–119.Google Scholar
  2. 2.
    Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Executive summary: heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133(4):447–54. doi: 10.1161/cir.0000000000000366.PubMedCrossRefGoogle Scholar
  3. 3.
    Mosca L, Ferris A, Fabunmi R, Robertson RM. Tracking women’s awareness of heart disease: an American Heart Association national study. Circulation. 2004;109(5):573–9. doi: 10.1161/01.cir.0000115222.69428.c9.PubMedCrossRefGoogle Scholar
  4. 4.
    Mosca L, Mochari-Greenberger H, Dolor RJ, Newby LK, Robb KJ. Twelve-year follow-up of American women’s awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010;3(2):120–7. doi: 10.1161/circoutcomes.109.915538.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29(7):932–40. doi: 10.1093/eurheartj/ehn018.PubMedCrossRefGoogle Scholar
  6. 6.
    Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification Of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol. 2005;45(6):832–7. doi: 10.1016/j.jacc.2004.11.055.PubMedCrossRefGoogle Scholar
  7. 7.
    • Worrall-Carter L, McEvedy S, Wilson A, Rahman MA. Gender differences in presentation, coronary intervention, and outcomes of 28,985 acute coronary syndrome patients in Victoria, Australia. Womens Health Issues: Off Publ Jacobs Inst Womens Health. 2016;26(1):14–20. doi: 10.1016/j.whi.2015.09.002. This large study showed that compared with men, women were older and more likely to present with multiple comorbidities. Women were also less likely to receive coronary interventions after admission for ACS, revealing a gender bias in decisions to pursue angiography.CrossRefGoogle Scholar
  8. 8.
    Lansky AJ, Ng VG, Maehara A, Weisz G, Lerman A, Mintz GS, et al. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. J Am Coll Cardiol Img. 2012;5(3 Suppl):S62–72. doi: 10.1016/j.jcmg.2012.02.003.CrossRefGoogle Scholar
  9. 9.
    Dreyer RP, Smolderen KG, Strait KM, Beltrame JF, Lichtman JH, Lorenze NP, et al. Gender differences in pre-event health status of young patients with acute myocardial infarction: a VIRGO study analysis. Eur Heart J Acute Cardiovasc Care. 2016;5(1):43–54. doi: 10.1177/2048872615568967.PubMedCrossRefGoogle Scholar
  10. 10.
    Leung Yinko SS, Maheswaran J, Pelletier R, Bacon SL, Daskalopoulou SS, Khan NA, et al. Sex differences in health behavior change after premature acute coronary syndrome. Am Heart J. 2015;170(2):242–8. doi: 10.1016/j.ahj.2015.04.016.PubMedCrossRefGoogle Scholar
  11. 11.
    Parashar S, Rumsfeld JS, Reid KJ, Buchanan D, Dawood N, Khizer S, et al. Impact of depression on sex differences in outcome after myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009;2(1):33–40. doi: 10.1161/circoutcomes.108.818500.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Davis M, Diamond J, Montgomery D, Krishnan S, Eagle K, Jackson E. Acute coronary syndrome in young women under 55 years of age: clinical characteristics, treatment, and outcomes. Clin Res Cardiol: Off J German Cardiac Soc. 2015;104(8):648–55. doi: 10.1007/s00392-015-0827-2.CrossRefGoogle Scholar
  13. 13.
    Canto JG, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V, et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA. 2012;307(8):813–22. doi: 10.1001/jama.2012.199.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Chakrabarti S, Morton JS, Davidge ST. Mechanisms of estrogen effects on the endothelium: an overview. Can J Cardiol. 2014;30(7):705–12. doi: 10.1016/j.cjca.2013.08.006.PubMedCrossRefGoogle Scholar
  15. 15.
    Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280(7):605–13.PubMedCrossRefGoogle Scholar
  16. 16.
    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.PubMedCrossRefGoogle Scholar
  17. 17.
    Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366(24):2257–66. doi: 10.1056/NEJMoa1111840.PubMedCrossRefGoogle Scholar
  18. 18.
    Diercks DB, Owen KP, Kontos MC, Blomkalns A, Chen AY, Miller C, et al. Gender differences in time to presentation for myocardial infarction before and after a national women’s cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG). Am Heart J. 2010;160(1):80–7.e3. doi: 10.1016/j.ahj.2010.04.017.PubMedCrossRefGoogle Scholar
  19. 19.
    •• Gupta A, Wang Y, Spertus JA, Geda M, Lorenze N, Nkonde-Price C, et al. Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J Am Coll Cardiol. 2014;64(4):337–45. doi: 10.1016/j.jacc.2014.04.054. This study used the National Inpatient Sample database and had a sample size of more than 230,000 hospitalizations with principle discharge diagnosis of AMI. The study showed that young women had higher in-hospital mortality and longer length of stay compared with men. It also showed that AMI hospitalization rates did not decline for young women from 2001 to 2010.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Dreyer RP, Ranasinghe I, Wang Y, Dharmarajan K, Murugiah K, Nuti SV, et al. Sex differences in the rate, timing, and principal diagnoses of 30-day readmissions in younger patients with acute myocardial infarction. Circulation. 2015;132(3):158–66. doi: 10.1161/circulationaha.114.014776.PubMedCrossRefGoogle Scholar
  21. 21.
    •• Davis MB, Maddox TM, Langner P, Plomondon ME, Rumsfeld JS, Duvernoy CS. Characteristics and outcomes of women veterans undergoing cardiac catheterization in the Veterans Affairs Healthcare System: insights from the VA CART Program. Circ Cardiovasc Qual Outcomes. 2015;8(2 Suppl 1):S39–47. doi: 10.1161/circoutcomes.114.001613. This is the first study of national VA data to investigate sex differences in veterans undergoing cardiac catheterization. The study identified higher rates of obesity, depression, and PTSD in women compared to men presenting with ACS. It further showed that women veterans had lower rates of obstructive CAD compared to male veterans.PubMedCrossRefGoogle Scholar
  22. 22.
    Shah AJ, Ghasemzadeh N, Zaragoza-Macias E, Patel R, Eapen DJ, Neeland IJ, et al. Sex and age differences in the association of depression with obstructive coronary artery disease and adverse cardiovascular events. J Am Heart Assoc. 2014;3(3), e000741. doi: 10.1161/JAHA.113.000741.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, et al. Depression and cardiovascular sequelae in postmenopausal women. The Women’s Health Initiative (WHI). Arch Intern Med. 2004;164(3):289–98. doi: 10.1001/archinte.164.3.289.PubMedCrossRefGoogle Scholar
  24. 24.
    Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350–69. doi: 10.1161/CIR.0000000000000019.PubMedCrossRefGoogle Scholar
  25. 25.
    Mehta PK, Wei J, Wenger NK. Ischemic heart disease in women: a focus on risk factors. Trends Cardiovasc Med. 2015;25(2):140–51. doi: 10.1016/j.tcm.2014.10.005.PubMedCrossRefGoogle Scholar
  26. 26.
    Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929–38. doi: 10.1056/NEJMoa1406761.PubMedCrossRefGoogle Scholar
  27. 27.
    Safford MM, Brown TM, Muntner PM, Durant RW, Glasser S, Halanych JH, et al. Association of race and sex with risk of incident acute coronary heart disease events. JAMA. 2012;308(17):1768–74. doi: 10.1001/jama.2012.14306.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Mehta RH, Marks D, Califf RM, Sohn S, Pieper KS, Van de Werf F, et al. Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction. Am J Med. 2006;119(1):70.e1–8. doi: 10.1016/j.amjmed.2005.07.043.CrossRefGoogle Scholar
  29. 29.
    Jose PO, Frank AT, Kapphahn KI, Goldstein BA, Eggleston K, Hastings KG, et al. Cardiovascular disease mortality in Asian Americans. J Am Coll Cardiol. 2014;64(23):2486–94. doi: 10.1016/j.jacc.2014.08.048.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, et al. Rising tide of cardiovascular disease in American Indians. Strong Heart Study Circ. 1999;99(18):2389–95.Google Scholar
  31. 31.
    White SJ, Newby AC, Johnson TW. Endothelial erosion of plaques as a substrate for coronary thrombosis. Thromb Haemost. 2016;115(3):509–19. doi: 10.1160/TH15-09-0765.PubMedCrossRefGoogle Scholar
  32. 32.
    Arbustini E, Dal Bello B, Morbini P, Burke AP, Bocciarelli M, Specchia G, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart. 1999;82(3):269–72.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93(7):1354–63.PubMedCrossRefGoogle Scholar
  34. 34.
    Kramer MC, Rittersma SZ, de Winter RJ, Ladich ER, Fowler DR, Liang YH, et al. Relationship of thrombus healing to underlying plaque morphology in sudden coronary death. J Am Coll Cardiol. 2010;55(2):122–32. doi: 10.1016/j.jacc.2009.09.007.PubMedCrossRefGoogle Scholar
  35. 35.
    Pepine CJ, Ferdinand KC, Shaw LJ, Light-McGroary KA, Shah RU, Gulati M, et al. Emergence of nonobstructive coronary artery disease: a Woman’s problem and need for change in definition on angiography. J Am Coll Cardiol. 2015;66(17):1918–33. doi: 10.1016/j.jacc.2015.08.876.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Jespersen L, Hvelplund A, Abildstrom SZ, Pedersen F, Galatius S, Madsen JK, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734–44. doi: 10.1093/eurheartj/ehr331.PubMedCrossRefGoogle Scholar
  37. 37.
    Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, et al. Insights from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 Suppl):S21–9. doi: 10.1016/j.jacc.2004.12.084.PubMedCrossRefGoogle Scholar
  38. 38.
    •• Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, et al. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 2016;133(9):916–47. doi: 10.1161/cir.0000000000000351. This is the first scientific statement from the American Heart Association on acute myocardial infarction in women and provides a comprehensive review of current evidence of the clinical presentation, pathophysiology, treatment, and outcomes of women with acute myocardial infarction.PubMedCrossRefGoogle Scholar
  39. 39.
    Schwartz RS, Burke A, Farb A, Kaye D, Lesser JR, Henry TD, et al. Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology. J Am Coll Cardiol. 2009;54(23):2167–73. doi: 10.1016/j.jacc.2009.07.042.PubMedCrossRefGoogle Scholar
  40. 40.
    Chandrasekhar J, Mehran R. Sex-based differences in acute coronary syndromes: insights from invasive and noninvasive coronary technologies. J Am Coll Cardiol Img. 2016;9(4):451–64. doi: 10.1016/j.jcmg.2016.02.004.CrossRefGoogle Scholar
  41. 41.
    Jones E, Eteiba W, Merz NB. Cardiac syndrome X and microvascular coronary dysfunction. Trends Cardiovasc Med. 2012;22(6):161–8. doi: 10.1016/j.tcm.2012.07.014.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Duvernoy CS. Coronary heart disease in women: what do we know now? Futur Cardiol. 2005;1(5):617–28. doi: 10.2217/14796678.1.5.617.CrossRefGoogle Scholar
  43. 43.
    Duvernoy CS, Smith DE, Manohar P, Schaefer A, Kline-Rogers E, Share D, et al. Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry. Am Heart J. 2010;159(4):677–83.e1. doi: 10.1016/j.ahj.2009.12.040.PubMedCrossRefGoogle Scholar
  44. 44.
    • Lee BK, Lim HS, Fearon WF, Yong AS, Yamada R, Tanaka S, et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation. 2015;131(12):1054–60. doi: 10.1161/CIRCULATIONAHA.114.012636. This study assessed endothelial function in patients with angina who did not have obstructive CAD. Microcirculatory resistance, coronary flow reserve, and fractional flow reserve were measured, and occult coronary abnormalities were found in more than three quarters of patients.PubMedCrossRefGoogle Scholar
  45. 45.
    Nahser Jr PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation. 1995;91(3):635–40.PubMedCrossRefGoogle Scholar
  46. 46.
    Iozzo P, Chareonthaitawee P, Rimoldi O, Betteridge DJ, Camici PG, Ferrannini E. Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with type II diabetes. Diabetologia. 2002;45(10):1404–9. doi: 10.1007/s00125-002-0917-3.PubMedCrossRefGoogle Scholar
  47. 47.
    Prior JO, Quinones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW, et al. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation. 2005;111(18):2291–8. doi: 10.1161/01.cir.0000164232.62768.51.PubMedCrossRefGoogle Scholar
  48. 48.
    Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126(15):1858–68. doi: 10.1161/circulationaha.112.120402.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Lautamaki R, Airaksinen KE, Seppanen M, Toikka J, Harkonen R, Luotolahti M, et al. Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease. Diabetes. 2006;55(2):511–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Schelbert HR. Coronary circulatory function abnormalities in insulin resistance: insights from positron emission tomography. J Am Coll Cardiol. 2009;53(5 Suppl):S3–8. doi: 10.1016/j.jacc.2008.09.053.PubMedCrossRefGoogle Scholar
  51. 51.
    Galiuto L, De Caterina AR, Porfidia A, Paraggio L, Barchetta S, Locorotondo G, et al. Reversible coronary microvascular dysfunction: a common pathogenic mechanism in apical ballooning or takotsubo syndrome. Eur Heart J. 2010;31(11):1319–27. doi: 10.1093/eurheartj/ehq039.PubMedCrossRefGoogle Scholar
  52. 52.
    Dey S, Flather MD, Devlin G, Brieger D, Gurfinkel EP, Steg PG, et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart. 2009;95(1):20–6. doi: 10.1136/hrt.2007.138537.PubMedCrossRefGoogle Scholar
  53. 53.
    Khan NA, Daskalopoulou SS, Karp I, Eisenberg MJ, Pelletier R, Tsadok MA, et al. Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med. 2013;173(20):1863–71. doi: 10.1001/jamainternmed.2013.10149.PubMedGoogle Scholar
  54. 54.
    Arslanian-Engoren C, Patel A, Fang J, Armstrong D, Kline-Rogers E, Duvernoy CS, et al. Symptoms of men and women presenting with acute coronary syndromes. Am J Cardiol. 2006;98(9):1177–81. doi: 10.1016/j.amjcard.2006.05.049.PubMedCrossRefGoogle Scholar
  55. 55.
    Lichtman JH, Leifheit-Limson EC, Watanabe E, Allen NB, Garavalia B, Garavalia LS, et al. Symptom recognition and healthcare experiences of young women with acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2015;8(2 Suppl 1):S31–8. doi: 10.1161/CIRCOUTCOMES.114.001612.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Daniels LB, Maisel AS. Cardiovascular biomarkers and sex: the case for women. Nat Rev Cardiol. 2015;12(10):588–96. doi: 10.1038/nrcardio.2015.105.PubMedCrossRefGoogle Scholar
  57. 57.
    • Slagman A, Searle J, Vollert JO, Storchmann H, Buschenfelde DM, von Recum J, et al. Sex differences of troponin test performance in chest pain patients. Int J Cardiol. 2015;187:246–51. doi: 10.1016/j.ijcard.2015.03.261. This study showed that cardiac troponin levels in ACS are influenced by the patient’s sex and found that there is a lower sensitivity and negative predictive value in women compared with men.PubMedCrossRefGoogle Scholar
  58. 58.
    Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ (Clin Res ed). 2015;350:g7873. doi: 10.1136/bmj.g7873.Google Scholar
  59. 59.
    Trambas C, Pickering JW, Than M, Bain C, Nie L, Paul E, et al. Impact of high-sensitivity troponin I testing with sex-specific cutoffs on the diagnosis of acute myocardial infarction. Clin Chem. 2016;62(6):831–8. doi: 10.1373/clinchem.2015.252569.PubMedCrossRefGoogle Scholar
  60. 60.
    Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, McCabe CH, et al. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (treat angina with aggrastat and determine cost of therapy with an invasive or conservative strategy-thrombolysis in myocardial infarction 18) substudy. Circulation. 2004;109(5):580–6. doi: 10.1161/01.cir.0000109491.66226.26.PubMedCrossRefGoogle Scholar
  61. 61.
    Murthy VL, Naya M, Taqueti VR, Foster CR, Gaber M, Hainer J, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129(24):2518–27. doi: 10.1161/circulationaha.113.008507.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol. 2013;62(19):1748–58. doi: 10.1016/j.jacc.2013.05.071.PubMedCrossRefGoogle Scholar
  63. 63.
    Acharjee S, Teo KK, Jacobs AK, Hartigan PM, Barn K, Gosselin G, et al. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: a pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. Am Heart J. 2016;173:108–17. doi: 10.1016/j.ahj.2015.07.020.PubMedCrossRefGoogle Scholar
  64. 64.
    Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503–15. doi: 10.1056/NEJMoa0805796.PubMedCrossRefGoogle Scholar
  65. 65.
    Tamis-Holland JE, Lu J, Korytkowski M, Magee M, Rogers WJ, Lopes N, et al. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes). J Am Coll Cardiol. 2013;61(17):1767–76. doi: 10.1016/j.jacc.2013.01.062.PubMedCrossRefGoogle Scholar
  66. 66.
    Lagerqvist B, Safstrom K, Stahle E, Wallentin L, Swahn E. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators. J Am Coll Cardiol. 2001;38(1):41–8.PubMedCrossRefGoogle Scholar
  67. 67.
    O’Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA. 2008;300(1):71–80. doi: 10.1001/jama.300.1.71.PubMedCrossRefGoogle Scholar
  68. 68.
    Amsterdam EA, Wenger NK, Brindis RG, Casey Jr DE, Ganiats TG, Holmes Jr DR, et al. 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–228. doi: 10.1016/j.jacc.2014.09.017.PubMedCrossRefGoogle Scholar
  69. 69.
    Radovanovic D, Erne P, Urban P, Bertel O, Rickli H, Gaspoz JM. Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry. Heart. 2007;93(11):1369–75. doi: 10.1136/hrt.2006.106781.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Fang J, Alderman MH. Gender differences of revascularization in patients with acute myocardial infarction. Am J Cardiol. 2006;97(12):1722–6. doi: 10.1016/j.amjcard.2006.01.032.PubMedCrossRefGoogle Scholar
  71. 71.
    • D’Onofrio G, Safdar B, Lichtman JH, Strait KM, Dreyer RP, Geda M, et al. Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: results from the VIRGO study. Circulation. 2015;131(15):1324–32. doi: 10.1161/CIRCULATIONAHA.114.012293. This study revealed that young women with ST-segment elevation myocardial infarction are less likely to receive reperfusion therapy and more likely to have reperfusion delays than similarly aged men.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Puymirat E, Taldir G, Aissaoui N, Lemesle G, Lorgis L, Cuisset T, et al. Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome). J Am Coll Cardiol Intv. 2012;5(9):893–902. doi: 10.1016/j.jcin.2012.05.008.CrossRefGoogle Scholar
  73. 73.
    Baber U, Giustino G, Wang T, Grines C, McCoy LA, Saha-Chaudhuri P, et al. Comparisons of the uptake and in-hospital outcomes associated with second-generation drug-eluting stents between men and women: results from the CathPCI Registry. Coron Artery Dis. 2016;27(6):442–8. doi: 10.1097/mca.0000000000000376.PubMedCrossRefGoogle Scholar
  74. 74.
    • Giustino G, Baber U, Stefanini GG, Aquino M, Stone GW, Sartori S, et al. Impact of clinical presentation (stable angina pectoris vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction) on long-term outcomes in women undergoing percutaneous coronary intervention with drug-eluting stents. Am J Cardiol. 2015;116(6):845–52. doi: 10.1016/j.amjcard.2015.06.010. This study pooled data for women in 26 randomized trials found that new-generation DESs provide improved long-term clinical outcomes irrespective of the clinical presentation in women.PubMedCrossRefGoogle Scholar
  75. 75.
    Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation. 2009;119(14):1873–82. doi: 10.1161/circulationaha.108.828541.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Gharacholou SM, Alexander KP, Chen AY, Wang TY, Melloni C, Gibler WB, et al. Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative. Am Heart J. 2010;159(5):757–63. doi: 10.1016/j.ahj.2010.02.009.PubMedCrossRefGoogle Scholar
  77. 77.
    O’Gara PT, Kushner FG, Ascheim DD, Casey Jr DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013;82(1):E1–27. doi: 10.1002/ccd.24776.PubMedCrossRefGoogle Scholar
  78. 78.
    Motovska Z, Widimsky P, Aschermann M. The impact of gender on outcomes of patients with ST elevation myocardial infarction transported for percutaneous coronary intervention: analysis of the PRAGUE-1 and 2 studies. Heart. 2008;94(3):e5. doi: 10.1136/hrt.2006.110866.PubMedCrossRefGoogle Scholar
  79. 79.
    Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerci A, et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. JAMA. 1996;275(10):777–82.PubMedCrossRefGoogle Scholar
  80. 80.
    Akhter N, Milford-Beland S, Roe MT, Piana RN, Kao J, Shroff A. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am Heart J. 2009;157(1):141–8. doi: 10.1016/j.ahj.2008.08.012.PubMedCrossRefGoogle Scholar
  81. 81.
    Tavris DR, Gallauresi BA, Dey S, Brindis R, Mitchel K. Risk of local adverse events by gender following cardiac catheterization. Pharmacoepidemiol Drug Saf. 2007;16(2):125–31. doi: 10.1002/pds.1307.PubMedCrossRefGoogle Scholar
  82. 82.
    Rao SV, Ou FS, Wang TY, Roe MT, Brindis R, Rumsfeld JS, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. J Am Coll Cardiol Intv. 2008;1(4):379–86. doi: 10.1016/j.jcin.2008.05.007.CrossRefGoogle Scholar
  83. 83.
    Agostoni P, Biondi-Zoccai GG, de Benedictis ML, Rigattieri S, Turri M, Anselmi M, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;44(2):349–56. doi: 10.1016/j.jacc.2004.04.034.PubMedCrossRefGoogle Scholar
  84. 84.
    Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol. 2007;49(12):1362–8. doi: 10.1016/j.jacc.2007.02.027.PubMedCrossRefGoogle Scholar
  85. 85.
    Swaminathan RV, Feldman DN, Pashun RA, Patil RK, Shah T, Geleris JD, et al. Gender differences in in-hospital outcomes after coronary artery bypass grafting. Am J Cardiol. 2016;118(3):362–8. doi: 10.1016/j.amjcard.2016.05.004.PubMedCrossRefGoogle Scholar
  86. 86.
    Brown PP, Mack MJ, Simon AW, Battaglia S, Tarkington L, Horner S, et al. Outcomes experience with off-pump coronary artery bypass surgery in women. Ann Thorac Surg. 2002;74(6):2113–9. discussion 20.PubMedCrossRefGoogle Scholar
  87. 87.
    Anand SS, Xie CC, Mehta S, Franzosi MG, Joyner C, Chrolavicius S, et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol. 2005;46(10):1845–51. doi: 10.1016/j.jacc.2005.05.091.PubMedCrossRefGoogle Scholar
  88. 88.
    •• Smolina K, Ball L, Humphries KH, Khan N, Morgan SG. Sex disparities in post-acute myocardial infarction pharmacologic treatment initiation and adherence: problem for young women. Circ Cardiovasc Qual Outcomes. 2015;8(6):586–92. doi: 10.1161/circoutcomes.115.001987. This study revealed that women <55 years old are significantly less likely to be on optimal therapy by the end of 1 year after discharge compared with men. This difference is driven by a sex disparity in treatment initiation and not treatment adherence.PubMedGoogle Scholar
  89. 89.
    Maddox TM, Ho PM, Roe M, Dai D, Tsai TT, Rumsfeld JS. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry. Circ Cardiovasc Qual Outcomes. 2010;3(6):632–41. doi: 10.1161/circoutcomes.109.906214.PubMedCrossRefGoogle Scholar
  90. 90.
    Humphries KH, Pu A, Gao M, Carere RG, Pilote L. Angina with “normal” coronary arteries: sex differences in outcomes. Am Heart J. 2008;155(2):375–81. doi: 10.1016/j.ahj.2007.10.019.PubMedCrossRefGoogle Scholar
  91. 91.
    • Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312(17):1754–63. doi: 10.1001/jama.2014.14681. This study showed that patients with nonobstructive CAD compared with no apparent CAD had a significantly greater 1-year risk of MI and all-cause mortality. These findings highlight the clinic importance of nonobstructive CAD.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Berger JS, Bhatt DL, Cannon CP, Chen Z, Jiang L, Jones JB, et al. The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis. J Am Coll Cardiol. 2009;54(21):1935–45. doi: 10.1016/j.jacc.2009.05.074.PubMedCrossRefGoogle Scholar
  93. 93.
    Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, et al. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J. 2014;35(23):1541–50. doi: 10.1093/eurheartj/ehu075.PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045–57. doi: 10.1056/NEJMoa0904327.PubMedCrossRefGoogle Scholar
  95. 95.
    Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001–15. doi: 10.1056/NEJMoa0706482.PubMedCrossRefGoogle Scholar
  96. 96.
    Alexander KP, Chen AY, Newby LK, Schwartz JB, Redberg RF, Hochman JS, et al. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation. 2006;114(13):1380–7. doi: 10.1161/circulationaha.106.620815.PubMedCrossRefGoogle Scholar
  97. 97.
    White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, et al. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol. 2008;52(10):807–14. doi: 10.1016/j.jacc.2008.05.036.PubMedCrossRefGoogle Scholar
  98. 98.
    Wang WT, James SK, Wang TY. A review of sex-specific benefits and risks of antithrombotic therapy in acute coronary syndrome. Eur Heart J. 2016. doi: 10.1093/eurheartj/ehv758.PubMedCentralGoogle Scholar
  99. 99.
    Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, Stason WB. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation. 2007;116(15):1653–62. doi: 10.1161/circulationaha.107.701466.PubMedCrossRefGoogle Scholar
  100. 100.
    • Pouche M, Ruidavets JB, Ferrieres J, Iliou MC, Douard H, Lorgis L, et al. Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: the 2005 French FAST-MI study. Arch Cardiovasc Dis. 2016;109(3):178–87. doi: 10.1016/j.acvd.2015.09.009. This study showed that among patients admitted for ACS, fewer women compared to men were referred to cardiac rehabilitation at hospital discharge. The 5-year survival was significantly improved in patients who participated in cardiac rehabilitation.PubMedCrossRefGoogle Scholar
  101. 101.
    Mochari H, Lee JR, Kligfield P, Mosca L. Ethnic differences in barriers and referral to cardiac rehabilitation among women hospitalized with coronary heart disease. Prev Cardiol. 2006;9(1):8–13.PubMedCrossRefGoogle Scholar
  102. 102.
    Beckie TM, Beckstead JW, Schocken DD, Evans ME, Fletcher GF. The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: a randomized clinical trial. Int J Nurs Stud. 2011;48(1):3–12. doi: 10.1016/j.ijnurstu.2010.06.005.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2016

Authors and Affiliations

  • Kris R. Kawamoto
    • 1
    • 2
  • Melinda B. Davis
    • 1
    • 2
  • Claire S. Duvernoy
    • 1
    • 2
  1. 1.Division of Cardiovascular Medicine, Department of Internal MedicineUniversity of MichiganAnn ArborUSA
  2. 2.Cardiology Section, Medical ServiceVA Ann Arbor Healthcare SystemAnn ArborUSA

Personalised recommendations